Mode of Action of RU 486

References

• Teutsch G. Analogues of RU 486 for the mapping of the progestin receptor: synthetic and structural acpects. The antiprogestin steroid RU 486 and human fertility control., E E. Baulieu, S J. Segal. Plenum Press, New York 1985; 27–47
   Google Scholar
• Baulieu E E. Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor level. Science 1989; 245: 1351–7
   PubMed Web of Science ®Google Scholar
• Swahn M L., Johannisson E, Daniore V, Van den Torre B, Bygdeman M. The effect of RU 486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium. Human Reprod 1988; 3: 915–21
   PubMed Web of Science ®Google Scholar
• Croxatto H B., Salvatierra A M. Cyclic use of antigestagens for fertility control. Female contraception and male fertility regulation., B Runnebaum, T Rabe, L Kiesel. Parthenon Publishing, Camforth, U.K. 1990; 245–52
   Google Scholar
• Swahn M L., Bygdeman M, Xing S, Cekan S, Masironi B, Johannisson E. The effects of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Human Reprod 1990; 5: 402–8
   PubMed Web of Science ®Google Scholar
• Berthois Y, Salat-Baroux J, Cornat J, De Brux J, Kopp F, Van den Martin P. A multiparametric analysis of endometrial estrogen and progesterone receptors after the post-ovulatory administration of mifepristone. Fertil Steril 1991; 55: 547–54
   PubMed Web of Science ®Google Scholar
• Swahn M L., Gemzell K, Bygdeman M. Contraception with mifepristone. Lancet 1991; 338: 942–3
   PubMed Web of Science ®Google Scholar
• Croxatto H B., Spitz I M., Salvatierra A M. The demonstration of the antiprogestin effects of RU 486 when administered during hCG-induced pseudopregnancy. Human fertility control., E E. Baulieu, S Segal. Plenum Press, New York 1985; 263–70
   Google Scholar
• Schoupe D, Mishell D R., Jr, Lähteenmäki P, et al. Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phase. Am J Obstet Gynecol 1987; 157: 1415–20
   PubMed Web of Science ®Google Scholar
• Garzo V G., Llu J, Ulmann A, Baulieu E E., Yen S SC. Effects of an antiprogesterone (RU 486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle. J Clin Endocrinol Metab 1988; 66: 508–17
   PubMed Web of Science ®Google Scholar
• DiMattina M, Albertsson B, Seyler D E., Lorlaux D L., Falk R J. Effect of the antiprogestin RU 486 on progesterone production by cultured human granulosa cells: inhibition of the ovarian 3β-hydroxy steroid dehydrogenase. Contraception 1986; 34: 199–206
   PubMed Web of Science ®Google Scholar
• Gemzell K, Swahn M L., Bygdeman M. Regulation of nonpregnant human uterine contractility. Effect of anti-hormones. Contraception 1990; 42: 323–35
   PubMed Web of Science ®Google Scholar
• Van Look P FA, Bygdeman M. Antiprogestational steroids: a new dimension in human fertility regulation. Oxf Rev Reprod Biol 1989; 11: 2–60
   PubMedGoogle Scholar
• Smith S K., Kelly R W. The effect of the antiprogestins RU 486 and ZK 98, 734 on the synthesis and metabolism of prostaglandins F2a and E2 in separated cells from early human decidua. J Clin Endocrinol Metab 1987; 65: 527–34
   PubMed Web of Science ®Google Scholar
• Swahn M L., Bygdeman M. The effect of the antiprogestin RU 486 on uterine contractility and sensitivity to prostaglandin and oxytocin. Br J Obstet Gynaecol 1988; 95: 126–34
   PubMedGoogle Scholar
• Silvestre L, Dubois C, Renault M, Rezvanl Y, Baulieu E E., Ulmann A A. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. N Engl J Med 1990; 322: 645–8
   PubMed Web of Science ®Google Scholar
• Multicentre U.K. study. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy. Br J Obstet Gynaecol 1990; 97: 480–6
   PubMedGoogle Scholar
• Gemzell K, Swahn M L., Bygdeman M. The effect of antiprogestin, hCG and a prostaglandin analogue (Misoprostol) on human uterine contractility, (in press)
   Google Scholar
• Rådestad A, Bygdeman M, Gréen K. Induced cervical ripening with mifepristone (RU 486) and bioconversion of arachidonic acid in human pregnant cervix in the first trimester. A double blind, randomized, biomechanical and biochemical study. Contraception 1990; 41: 283–92
   PubMed Web of Science ®Google Scholar
• Rådestad A, Bygdeman M. Cervical softening with mifepristone (RU 486) after pretreatment with naproxen. A double-blind randomized study. Contraception 1992; 45: 221–7
   PubMed Web of Science ®Google Scholar
• Rodger M W., Balrd D T. Pretreatment with mifepristone (RU 486) reduces interval between prostaglandin administration and expulsion in second trimester abortion. Br J Obstet Gynaecol 1990; 97: 41–5
   PubMedGoogle Scholar
• Gottlieb C, Bygdeman M. The use of antiprogestin (RU 486) for termination of second trimester pregnancy. Acta Obstet Gynecol Scand 1991; 70: 199–203
   PubMed Web of Science ®Google Scholar